Canton Strategic Holdings (CNTN) reported total revenue of $1.50 million for the second quarter ended June 30, 2026, its first quarter generating revenue under its digital asset treasury strategy. The company reported a net loss of $19.25 million, including a $23.74 million unrealized loss on digital asset holdings.
Revenue included $1.30 million from locking-as-a-service and $191,226 from network validation operations. Canton Strategic also completed the July 17 sale of its legacy biotechnology subsidiary, Gravitas Life Sciences.
- Total revenue was $1,495,859, compared with zero in the prior-year quarter.
- Net loss from continuing operations was $17,954,081, or $0.08 per basic and diluted share.
- Canton Coin holdings totaled 3,714,204,876 units with a fair value of $523.35 million as of June 30.
- Cash and cash equivalents were $37.24 million at quarter end.
- The board approved a $50 million share repurchase program in June; no shares were repurchased during the period.
